Latest Infrastructure News

Saunders International reported a modest revenue dip and sharp profit decline in FY2025, offset by a transformative acquisition that expands its water infrastructure footprint and doubles its project pipeline.

Saunders International reported a slight revenue dip and a sharp EBITDA decline in FY2025, offset by a transformative acquisition that dramatically expands its order book and pipeline.

MetalsTech Limited has completed critical in-adit channel sampling for its Sturec Gold Project, progressing its Pre-Feasibility Study (PFS) on track for late 2025 completion. The company is leveraging technological innovations to enhance recoveries and reduce environmental impact.

Schaffer Corporation reported a 16% rise in underlying net profit for FY25, driven by strong Automotive Leather and Delta divisions, while maintaining its dividend and appointing a new CEO to steer future growth.

Lindian Resources has approved the Final Investment Decision for its Kangankunde Rare Earths Project, securing full funding and a strategic partnership with Iluka Resources. The company is raising A$91.5 million via institutional placement to advance development and expansion plans.

Lindian Resources has raised A$91.5 million through a strong institutional placement, enabling the final investment decision for the Kangankunde Rare Earths Project’s Stage 1 development with production targeted for late 2026.

Lycopodium Limited delivered robust FY25 financial results, hitting the top end of guidance with $339.6 million revenue and $42.2 million net profit. The company’s strategic SAXUM acquisition broadens its footprint in the Americas, positioning it well for growth in critical minerals and clean energy sectors.

TG Metals reports encouraging assay results from historical stockpiles and secures approvals for in-pit drilling at its Van Uden Gold Project, aiming to unlock near-term cash flow opportunities.

Pharmx Technologies reported a 13% increase in FY25 revenues to $7.53 million, driven by strong growth across its Gateway and Marketplace platforms. The company maintained positive EBITDA and a solid cash position despite legal expenses, setting the stage for an ambitious FY26 growth strategy.

Pharmx Technologies has reported a 13% revenue increase to $7.5 million for FY25, driven by expanded partnerships and platform innovations, despite a dip in EBITDA due to heavy investment.

Lycopodium Limited delivered FY25 results at the top end of guidance, reporting strong revenue and profit growth alongside strategic moves to deepen its global footprint, notably through the acquisition of Argentinian engineering firm SAXUM.

Pharmx Technologies Limited reported a 13% increase in revenue for FY25, driven by expanded supplier-pharmacy connections and Marketplace platform growth, while profit before tax declined due to significant investments in new technology platforms.